Abrdn PLC Regeneron Pharmaceuticals, Inc. Transaction History

Abrdn PLC

$57.3 Billion
Q2 2025

A detailed history of Abrdn PLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Abrdn PLC holds 203,750 shares of REGN stock, worth $114 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

203,750

Previous 245,197 16.9%

Holding current value

$114 Million

Previous $156 Million 31.22%

% of portfolio

0.19%

Previous 0.31%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	SELL	$483.07 - $625.6 $20 Million - $25.9 Million	-41,447 Reduced 16.9%	203,750 $107 Million
Q1 2025 May 13, 2025	BUY	$634.14 - $744.83 $36 Million - $42.3 Million	56,746 Added 30.11%	245,197 $156 Million
Q4 2024 Jan 24, 2025	BUY	$701.85 - $1046.91 $1.22 Million - $1.82 Million	1,740 Added 0.93%	188,451 $134 Million
Q3 2024 Oct 24, 2024	BUY	$1024.09 - $1201.76 $8.7 Million - $10.2 Million	8,494 Added 4.77%	186,711 $196 Million
Q2 2024 Aug 09, 2024	SELL	$883.2 - $1071.19 $37.1 Million - $45 Million	-42,032 Reduced 19.08%	178,217 $187 Million
Q1 2024 May 08, 2024	BUY	$902.69 - $993.35 $315,038 - $346,679	349 Added 0.16%	220,249 $212 Million
Q4 2023 Jan 31, 2024	BUY	$775.18 - $881.7 $144 Million - $164 Million	186,215 Added 552.81%	219,900 $193 Million
Q3 2023 Nov 06, 2023	SELL	$692.45 - $844.37 $312,294 - $380,810	-451 Reduced 1.32%	33,685 $27.7 Million
Q2 2023 Jun 20, 2024	BUY	$700.03 - $830.35 $196,008 - $232,498	280 Added 0.83%	34,136 $24.5 Million
Q2 2023 Aug 04, 2023	BUY	$700.03 - $830.35 $196,008 - $232,498	280 Added 0.83%	34,136 $24.5 Million
Q1 2023 Jun 20, 2024	BUY	$680.49 - $826.97 $346,369 - $420,927	509 Added 1.53%	33,856 $27.8 Million
Q1 2023 Apr 28, 2023	BUY	$680.49 - $826.97 $346,369 - $420,927	509 Added 1.53%	33,856 $27.8 Million
Q4 2022 Jun 20, 2024	SELL	$705.89 - $766.39 $132 Million - $143 Million	-186,902 Reduced 84.86%	33,347 $24.1 Million
Q4 2022 Feb 09, 2023	SELL	$705.89 - $766.39 $964,951 - $1.05 Million	-1,367 Reduced 3.94%	33,347 $24.1 Million
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $1.39 Million - $1.75 Million	2,415 Added 7.48%	34,714 $23.9 Million
Q2 2022 Aug 05, 2022	BUY	$548.35 - $738.84 $2.1 Million - $2.83 Million	3,830 Added 13.45%	32,299 $19.2 Million
Q1 2022 May 04, 2022	SELL	$595.12 - $698.43 $4.4 Million - $5.16 Million	-7,388 Reduced 20.6%	28,469 $20.1 Million
Q4 2021 Feb 08, 2022	SELL	$543.48 - $670.97 $1.06 Million - $1.31 Million	-1,957 Reduced 5.18%	35,857 $22.6 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $7.97 Million - $9.46 Million	-13,891 Reduced 26.87%	37,814 $23 Million
Q2 2021 Aug 10, 2021	SELL	$472.8 - $558.54 $10.6 Million - $12.5 Million	-22,347 Reduced 30.18%	51,705 $28.9 Million
Q1 2021 May 06, 2021	BUY	$446.73 - $548.2 $17 Million - $20.9 Million	38,151 Added 106.27%	74,052 $35 Million
Q4 2020 Feb 10, 2021	BUY	$478.3 - $607.98 $1.21 Million - $1.54 Million	2,527 Added 7.57%	35,901 $17.3 Million
Q3 2020 Oct 21, 2020	SELL	$544.75 - $658.21 $2.45 Million - $2.96 Million	-4,497 Reduced 11.87%	33,374 $18.7 Million
Q2 2020 Aug 10, 2020	BUY	$493.32 - $643.92 $2.52 Million - $3.29 Million	5,107 Added 15.59%	37,871 $23.6 Million
Q1 2020 May 13, 2020	SELL	$336.18 - $494.43 $66,899 - $98,391	-199 Reduced 0.6%	32,764 $16 Million
Q4 2019 Feb 18, 2020	SELL	$274.13 - $376.51 $136,790 - $187,878	-499 Reduced 1.49%	32,963 $12.4 Million
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $1.5 Million - $1.75 Million	-5,497 Reduced 14.11%	33,462 $9.28 Million
Q2 2019 Aug 13, 2019	SELL	$299.6 - $414.82 $208,521 - $288,714	-696 Reduced 1.76%	38,959 $12.2 Million
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $7.15 Million - $8.45 Million	19,223 Added 94.08%	39,655 $16.3 Million
Q4 2018 Feb 12, 2019	SELL	$335.82 - $403.04 $136,678 - $164,037	-407 Reduced 1.95%	20,432 $7.46 Million
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $843,789 - $981,649	2,403 Added 13.03%	20,839 $8.42 Million
Q2 2018 Aug 09, 2018	BUY	$284.6 - $344.99 $1.27 Million - $1.54 Million	4,468 Added 31.99%	18,436 $6.36 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $96,640 - $120,496	-306 Reduced 2.14%	13,968 $4.81 Million
Q4 2017 Feb 12, 2018	BUY	$358.63 - $469.95 $187,204 - $245,313	522 Added 3.8%	14,274 $5.37 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $5.93 Million - $6.93 Million	13,752	13,752 $6.15 Million

Others Institutions Holding REGN

# of Institutions

1,425

Shares Held

85.2M

Call Options Held

1.39M

Put Options Held

1.42M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $60B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account